Dr Linda D. Bradley on Inequities in Treating Endometriosis and Uterine Fibroids
May 1st 2023Optimal care that should be offered to all patients includes not only pain relief but also a complete pelvic exam and a discussion about the many options that are available for fibroids and endometriosis, including minimally invasive, organ-conserving surgery, said Linda D. Bradley, MD, professor of Obstetrics and Gynecology and Reproductive Medicine, Cleveland Clinic.
Read More
The European Union has proposed the biggest drug overhaul in 20 years, prompting industry conflict; CMS has proposed 2 new rules focused on increasing care access and quality of care for people enrolled in Medicaid and the Children’s Health Insurance Program; proposed legislation would promise $6 billion for treatments of drug-resistant infections that win approval.
Read More
FDA accelerates approval of drug for amyotrophic lateral sclerosis (ALS); hundreds of thousands could lose Medicaid coverage under Republican debt bill including work requirements; the Department of Veterans Affairs (VA) reports that half a million veterans have filed claims for health benefits related to toxic exposures.
Read More
Dr Raj Chovatiya on Optimizing Patient-Centered Care in Atopic Dermatitis
April 24th 2023By better understanding the nature of atopic dermatitis and its varying comorbidities, providers might be able to better predict patient outcomes, said Raj Chovatiya, MD, PhD, assistant professor of dermatology, Northwestern University Feinberg School of Medicine.
Read More
Globally, people lost confidence in the importance of routine childhood vaccines against lethal diseases like measles and polio, a survey finds; advocates say that the proposed price of about $50 a kit for naloxone could be too expensive; Bipartisan Senate legislation introduced this week would cap insulin at $35 per month for those with private insurance.
Read More
The White House intends to nominate Monica Bertagnolli to run the National Institutes of Health (NIH); Supreme Court asks for more time to decide if mifepristone use will have more restrictions, and providers look to misoprostol as an alternative; House Republicans presented a proposal to require certain low-income Americans to work or risk losing Medicaid coverage.
Read More
Updates From the SHEA Conference: Using EHRs to Find C difficile Earlier, and More
April 16th 2023Attendees at the Society for Healthcare Epidemiology of America (SHEA) 2023 Spring Conference heard presentations about using electronic health records to identify cases of Clostridioides difficile earlier, as well as an update about infection control strategies.
Read More
Governor Ron DeSantis signs 6-week abortion ban in Florida; Juul will pay Washington, DC, over $15 million as part of a settlement alleging the company marketed its products to teens; death counts attributed to malnutrition more than doubled from 2018 through 2022, with most deaths occurring to Californians 85 and older in 2022.
Read More
What We’re Reading: Restricted Abortion Pill; Cigna Drug Price Transparency; New Parkinson Research
April 13th 2023Judges reverted steps to make abortion pill mifepristone more accessible, but it is still available; Cigna Group will be offering an option for members that allows more visibility into manufacturer drug pricing and discounts; new research on Parkinson disease could lead to new diagnostics and treatments.
Read More
Affordable health care and drug use are the top 2 concerns of Americans; a new electronic records system set to be rolled out to multiple hospitals within the Department of Veterans Affairs has been suspended; the Environmental Protection Agency is proposing to measure certain hazardous chemicals extending beyond plant property lines.
Read More
What You May Have Missed at the AAD 2023 Annual Meeting
April 6th 2023The American Academy of Dermatology (AAD) 2023 Annual Meeting took place last month in New Orleans, Louisiana, and The American Journal of Managed Care® was there to cover the latest news—catch up on what you may have missed.
Read More